The adult mammalian brain contains multiple populations of endogenous progenitor cell types. However, following CNS trauma or disease, the regenerative capacity of progenitor populations is typically insufficient and may actually be limited by non-permissive or inhibitory signals in the damaged parenchyma. Remyelination is the most effective and simplest regenerative process in the adult CNS yet is still insufficient following repeated or chronic demyelination. Our previous in vitro studies demonstrated that fibroblast growth factor receptor 1 (FGFR1) signaling inhibited oligodendrocyte progenitor (OP) differentiation into mature oligodendrocytes. Therefore, we questioned whether FGFR1 signaling may inhibit the capacity of OP cells to generate oligodendrocytes in a demyelinating disease model and whether genetically reducing FGFR1 signaling in oligodendrocyte lineage cells could enhance the capacity for remyelination. FGFR1 was found to be upregulated in the corpus callosum during cuprizone mediated demyelination and expressed on OP cells just prior to remyelination. Plp/CreER T
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fl/fl mice were administered tamoxifen to induce conditional Fgfr1 deletion in oligodendrocyte lineage cells. Tamoxifen administration during chronic demyelination resulted in reduced FGFR1 expression in OP cells. OP proliferation and population size were not altered one week after tamoxifen treatment. Tamoxifen was then administered during chronic demyelination and mice were given a six week recovery period without cuprizone in the chow. After the recovery period, OP numbers were reduced and the number of mature oligodendrocytes was increased, indicating an effect of FGFR1 reduction on OP differentiation. Importantly, tamoxifen administration in Plp/CreER T :Fgfr1 fl/fl mice significantly promoted remyelination and axon integrity. These results demonstrate a direct effect of FGFR1 signaling in oligodendrocyte lineage cells as inhibiting the repair capacity of OP cells following chronic demyelination in the adult CNS. Published by Elsevier Inc.
Introduction
Optimization of the endogenous neural stem and progenitor cell capacity for repair of the adult CNS is a high priority among regenerative medicine approaches for diverse forms of CNS injury and disease. Remyelination is an excellent example of successful endogenous cell repair in the adult CNS and a relatively simple model for interrogating the cellular and molecular interactions that impact the effectiveness of regenerative responses from neural stem and progenitor cells. In the mammalian brain, endogenous neural stem cells of the subventricular zone and oligodendrocyte progenitor (OP) cells of the white matter can effectively generate new oligodendrocytes and exhibit extensive remyelination after a transient episode of demyelination (Aguirre et al., 2007; Murtie et al., 2005b; Nait-Oumesmar et al., 2008) . However, with repeated or prolonged episodes of demyelination, OP cells become depleted and remyelination becomes less effective (Armstrong et al., 2006; Mason et al., 2004) .
Growth factors, cytokines, and extracellular matrix molecules that can influence the regenerative responses of endogenous neural stem and OP cells can be associated with demyelination and the associated pathological features, such as reactive astrogliosis, microglia/macrophage activation, and inflammatory cell infiltration. Modifying the molecular signals of the lesion environment may attenuate inhibitory signals and promote endogenous cell regenerative responses. Our previous analyses of fibroblast growth factor 2 (FGF2), which is upregulated in areas of demyelination, have demonstrated proof-of-concept that genetic deletion of Fgf2 can significantly improve spontaneous remyelination as well as reduce axonal damage associated with chronic demyelination (Armstrong et al., 2006 (Armstrong et al., , 2002 Tobin et al., 2011) .
To better design approaches that can improve endogenous cell regenerative responses, it is important to identify the specific mechanisms of action and potential therapeutic targets. In vitro studies demonstrated a significant role of fibroblast growth factor receptor 1 Neurobiology of Disease 45 (2012) 196-205 
